David Larsen
Stock Analyst at BTIG
(2.17)
# 2,787
Out of 4,896 analysts
76
Total ratings
38.33%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $16.96 | +47.41% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $7.56 | +32.36% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $60.20 | +32.89% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $23.22 | +20.61% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $47.89 | -26.92% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $94.48 | +37.60% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $21.24 | +45.95% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $162.80 | +59.71% | 2 | Nov 1, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $20.31 | -1.53% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $24.90 | +181.18% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.92 | +78.57% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $275.89 | -13.01% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.49 | +369.80% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $11.26 | +24.33% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.23 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $28.71 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $11.18 | +302.50% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.89 | +439.85% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.23 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.47 | +71.02% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.32 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.40 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $160.97 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $709.59 | -77.45% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.52 | +507.64% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.44 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $64.78 | +31.21% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $8.12 | +183.25% | 1 | Nov 2, 2017 |
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $16.96
Upside: +47.41%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.56
Upside: +32.36%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $60.20
Upside: +32.89%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $23.22
Upside: +20.61%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $47.89
Upside: -26.92%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $94.48
Upside: +37.60%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $21.24
Upside: +45.95%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $162.80
Upside: +59.71%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $20.31
Upside: -1.53%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $24.90
Upside: +181.18%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.92
Upside: +78.57%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $275.89
Upside: -13.01%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.49
Upside: +369.80%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $11.26
Upside: +24.33%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.23
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $28.71
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $11.18
Upside: +302.50%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.89
Upside: +439.85%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.23
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $20.47
Upside: +71.02%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.32
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $8.40
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $160.97
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $709.59
Upside: -77.45%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.52
Upside: +507.64%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.44
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $64.78
Upside: +31.21%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $8.12
Upside: +183.25%